Therefore, the inactivation or loss of Fbxo4 that occurs in melanoma and esophageal cancer unleashes cytoplasmic hnRNPK activity, unmasking malignant function though dysregulated translation of multiple mRNA targets that promote tumor progression. This evidence concerns the gene FBXO4 and neoplasm.